Category: Covid-19 Vaccine

Page 9«..891011..2030..»

What We’re Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA … – AJMC.com Managed Markets Network

July 9, 2024

COVID-19 Vaccination May Shield Children from Asthma Symptoms, Study Suggests

A study led by Nemours Childrens Health suggests that COVID-19 vaccination may help protect children aged 5 years and older from symptomatic asthma, according to Cidrap. By analyzing state-level data from 2018 to 2021, the researchers found that states with higher vaccination rates saw a decrease in parent-reported asthma symptoms among children. The study also noted that the link between vaccination and reduced asthma symptoms warrants further investigation to confirm these potential benefits.

New Cyberattack Reporting Rules Ignite Concerns in Health Care Sector

A proposed rule under the Cyber Incident Reporting for Critical Infrastructure Act is causing controversy in the health care industry, with fears that the new cyberattack reporting requirements may hinder crisis response efforts, according to Axios. The Cybersecurity and Infrastructure Security Agency's (CISA) proposed rules mandate rapid reporting of cyber incidents and ransoms, which health care providers argue could divert critical resources and expose sensitive security details. Health organizations are calling for more flexibility and clarity in the rules, emphasizing the need to balance timely information sharing with practical considerations for handling cyber threats effectively.

MA Misdiagnoses: Misleading Records and Costly Consequences

Medicare Advantage insurers, including UnitedHealth, have issued hundreds of thousands of questionable diagnoses, inflating their payments from the government by billions of dollars, according to an investigation by The Wall Street Journal. These practices include diagnosing conditions such as diabetic cataracts and HIV in patients who do not have these diseases, often without their knowledge or consent. While insurers claim these efforts improve care coordination, critics argue they exploit the system, resulting in significant costs to taxpayers and potential harm to patients.

Read more:

What We're Reading: COVID-19 Vaccine and Fewer Asthma Symptoms; Cyberattack Reporting Rule; MA ... - AJMC.com Managed Markets Network

COVID Variants KP.3 and KP.2 Are Driving a Summer Surge – Everyday Health

July 9, 2024

Summers nowadays bring not only anticipated sweltering heat waves, but also predicted seasonal surges in COVID-19 infections.

[1]

[2]

[3]

[4]

For the week ending July 6, positive COVID-19 tests crept up by 0.8 percent, COVID-related emergency room visits jumped by more than 23 percent, and hospitalizations increased by just over 13 percent.

Were seeing an anticipated summer bump, says William Schaffner, MD, an infectious disease specialist and a professor of preventive medicine and health policy at the Vanderbilt University School of Medicine in Nashville, Tennessee. COVID doesn't disappear during the summertime the way influenza does. If we look back over our past two years, weve had an increase during the summer months. It abates again in the fall, and then you get a real seasonal increase during the winter.

[5]

COVID figures are trending up due to a constellation of factors, including more people congregating close together, more people traveling, and more people going indoors to escape extreme heat, says Peter Chin-Hong, MD, an infectious disease specialist and a professor of medicine at the University of California San Francisco School of Medicine.

A new suite of variants and waning vaccine immunity may also be contributing to the problem, adds Dr. Chin-Hong.

Since COVID-19 initially swept through the world over four years ago, the virus has rapidly mutated. Many versions of the virus have been able to escape the immune defenses people have built up through previous infection or vaccination, although newer versions of COVID-19 havent been causing as much serious illness as the versions that occurred early on in the pandemic.

[3]

The highly transmissible LB.1 variant is closely related to the FLiRT strains but has an extra mutation. These top four variants are all descendants of the omicron variant JN.1, which now accounts for just over 7 percent of cases but made up more than half of infections at the end of March.

As the virus quickly changes, vaccine makers are trying to keep up and adjust their formulas to be more effective against circulating strains.

[6]

Dr. Schaffner notes that at this point, it is highly unlikely that the fall vaccine can be adjusted any further to directly address a newly rising variant like LB.1. There is a finite period of time to make these vaccines, get them bottled up, and distribute them, he says. The current dominant strains, however, are all subvariants of the omicron family, so the anticipation is that these vaccines for the KP strains will provide antibodies that will protect against LB.1.

[7]

With at least a mini COVID-19 wave happening now, people may wonder if they should wait for the new shots or take further protective action right away.

For Chin-Hong, the answer is pretty straightforward: Did you get the vaccine approved in the fall of 2023? If not, I would go ahead and get it, especially if you are older than 65 and immunocompromised, he says. Those 65 and older can also get another vaccine if four months have elapsed since the last one. That will still give you the ability to get the new vaccine with the flu shot in October or November.

[8]

[9]

[10]

Treatments such as nirmatrelvir and ritonavir (Paxlovid) and remdesivir (Veklury) have also proved to prevent an infection from becoming serious.

Fortunately, the hospitals have not been overwhelmed as in previous years, attesting to the collective immunity in the population, says Chin-Hong. Still, some people are at risk of getting seriously ill: mainly those older than 75 or those who are very immunocompromised who have not gotten the latest vaccine or [been] prescribed Paxlovid or remdesivir when infected.

[11]

Chin-Hong says hes seeing fewer symptoms that were common in 2020, like shortness of breath and loss of taste and smell, and that some people are experiencing nausea and diarrhea symptoms they may not realize can be linked to COVID-19.

Because COVID-19 symptoms are often similar to those of allergies (such as hay fever) or the common cold, doctors warn that the only way to know for sure is to take a COVID test especially if you are vulnerable to severe infection (if you are older, for instance, or are immunocompromised) and want to stave off serious disease with a course of Paxlovid. You should also test if you spend time with anyone at high risk whom you might infect.

Anecdotally, some people on social media are reporting a few fairly nasty effects from the currently circulating virus. A commentator for CNBC recently wrote on X:

Tested positive for COVID a few days ago. First three days of symptoms were worse than those of 2 years ago. Deep, lingering sore throat among them. Thank goodness for Paxlovid. Seems to be working. Mask up. The new variant appears to be making a bit of a summer surge.

Here is the original post:

COVID Variants KP.3 and KP.2 Are Driving a Summer Surge - Everyday Health

COVID-19 vaccination linked to reduced symptomatic child asthma – News-Medical.Net

July 9, 2024

In a recent study published in JAMA Network Open, researchers investigate the association between population-level coronavirus disease 2019 (COVID-19) mitigation strategies, including vaccination rates and face mask mandates, and the prevalence of symptomatic asthma among children.

Study:COVID-19 Vaccination and Parent-Reported Symptomatic Child Asthma Prevalence. Image Credit: SeventyFour / Shutterstock.com

Asthma was initially considered a significant risk factor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and subsequent hospitalization caused by COVID-19. Health professionals were concerned that children with asthma would be particularly vulnerable during the pandemic.

Some of the different measures that promoted or enforced social distancing during the initial stages of the pandemic were found to reduce childrens emergency visits and hospitalizations related to asthma. Likewise, vaccination efforts in 2020 and 2021 significantly reduced the risk of being infected with SARS-CoV-2 for both children and adults.

Vaccination against COVID-19 can confer additional protective benefits, such as reductions in asthma symptoms. However, these potential benefits have not been studied. Furthermore, the relationship between exposure to illness caused by COVID-19, mitigation strategies, and symptomatic asthma among children remains unclear.

Using a cross-sectional design and publicly available data, researchers examined state-level trends and associations to better understand how public health measures during the COVID-19 pandemic may have influenced asthma symptomatology in children.

The analysis included data on the prevalence of asthma symptoms in children that parents reported through the National Survey of Childrens Health during 2018-2019 and 2020-2021. These data were collected at the state level.

Additional data included age-adjusted COVID-19 mortality rates from the United States Centers for Disease Control and Prevention (CDC) for 2020 and 2021, the proportion of the population aged five years or older who received the primary COVID-19 vaccination series, and state-level mask mandates in closed spaces until August 2021.

Changes in the state-level prevalence of childhood asthma symptoms, as reported by parents, were recorded between 2018-2019 and 2020-2021. Time trends in these symptoms were subsequently assessed using statistical tests, whereas trend associations with other state-level covariates were determined using pairwise linear regression and pairwise correlation analyses.

The average rate of childhood asthma symptoms declined significantly from 7.8% in 2018-2019 to 6.9% in 2020-2021, an overall decrease of 0.85 percentage points. Notably, this reduction occurred amid significant public health efforts to control COVID-19, such as widespread vaccination and mandatory face masks.

During the same period, the average COVID-19 death rate at the state level rose from 80.3 to 99.3 for every 100,000 people in 2020 and 2021, respectively. By December 2021, the average COVID-19 vaccination rate at the state level was 72.3%.

A linear regression analysis showed that for every 10-percentage point increase in the coverage of COVID-19 vaccinations, the rate of parent-reported childhood asthma symptoms decreased by 0.4 percentage points. However, no significant association was observed between asthma symptoms and COVID-19 death rates or face mask mandates at the state level.

State-level COVID-19 vaccination rates were negatively associated with COVID-19 death rates in 2021 but not 2020. Comparatively, mandates for face masks were positively associated with higher vaccination rates.

These findings suggest that higher vaccination rates may provide broader health benefits beyond preventing COVID-19 by potentially reducing the rate of asthma symptoms in children.

Higher COVID-19 vaccination rates were associated with reduced parent-reported childhood asthma symptoms, whereas state-level COVID-19 mortality and face mask mandates were not significantly correlated.

The study findings emphasize the importance of vaccination in mitigating health risks during pandemics. The widespread COVID-19 vaccination also appears to have broader health benefits, as it reduces the prevalence of childhood asthma symptoms.

Notable strengths of the current study include the use of comprehensive state-level data and the focus on population-level trends. However, a significant limitation is the lack of specific data on vaccination rates for children with asthma, which prevents a direct comparison of vaccinated and unvaccinated children.

Future research should further explore this relationship and assess whether sustained vaccination efforts against COVID-19 can continue to mitigate asthma symptoms in children. Ongoing public health strategies are also needed to address chronic conditions during pandemics and emphasize the role of vaccination in protecting vulnerable populations.

Link:

COVID-19 vaccination linked to reduced symptomatic child asthma - News-Medical.Net

Higher Covid-19 Vaccination Rates Linked To Lower Prevalence Of Pediatric Asthma Symptoms – Forbes

July 9, 2024

Young girl using asthma inhaler. (Photo by Jeff Overs/BBC News & Current Affairs via Getty Images)

Higher Covid-19 vaccination rates are associated with protection against children experiencing symptomatic asthma, according to the findings of a new JAMA Network Open study. The researchers reported that for every increase of 10 percentage points in the coverage of Covid-19 vaccination, the prevalence of pediatric asthma symptoms decreased by 0.36 percentage points.

Asthma is one of the most common chronic illnesses among children in the United States, with about 4.7 million children experiencing symptoms each year, lead author Matthew M. Davis, Executive Vice-President, Enterprise Physician-in-Chief and Chief Scientific Officer of Nemours Childrens Health, said in a press release. Whether asthma is mild or severe, it affects childrens quality of life. So anything we can do to help kids avoid flare-ups is beneficial.

In 2020, healthcare providers and researchers observed that social distancing measures helped prevent children with asthma from being hospitalized or rushed to the emergency department. A year later in 2021, people had access to Covid-19 vaccines and they were widely administered to children and adults across the United States. Davis and colleagues conducted the study to investigate if the vaccines could be linked to some form of protection against symptomatic asthma.

We hypothesized that symptomatic asthma would be positively associated with population-level COVID-19 overall mortality (a proxy for SARS-CoV-2 exposure), and would be inversely associated with population-level completion of the COVID-19 primary vaccination series and with state face mask mandates, they wrote in the JAMA study.

The team analyzed state-level data of parent-reported asthma symptoms in their children from the National Survey of Childrens Health. They studied the data from 2018-2019 and then compared that to 2020-2021 data.

They found that the state-level prevalence of childhood asthma symptoms decreased from 7.77% in 2018-19 to 6.93% in 2020-21. The only bad news was that the Covid-19-related mortality rate increased from 80.3 per 100,000 people in 2020 to 99.3 in 2021. Community-level immunity in states with higher vaccination rates may have helped reduce childrens asthma risk, the authors stated.

In a press release, co-author Lakshmi Halasyamani, Chief Clinical Officer of Endeavor Health in Evanston, Illinois, said: Ongoing vaccination against COVID-19 may offer direct benefits for children with a history of asthma, but this must be confirmed with further research. It also raises the question of whether broader population-level COVID-19 vaccination among children and adults can help protect children with asthma, too.

However, a major limitation of the study is that state-level estimates of Covid-19 vaccination rates among children with a history of asthma were unavailable. Because of that, the researchers were not able to investigate differences in asthma symptoms among vaccinated and unvaccinated children. "These findings merit further assessment to determine whether childhood asthma symptom prevalence may be reduced by sustained vaccination efforts against SARS-CoV-2," the authors concluded.

According to the Centers for Disease Control and Prevention (CDC), the prevalence of pediatric asthma in the United States was 9.5% in 2011. But in 2021, the prevalence decreased to 6.5%. Male children are far more likely to be diagnosed with asthma than female children. The Asthma and Allergy Foundation of America reported that while 7% of male children have asthma, 5.4% of female children were diagnosed with the respiratory condition.

Here is the original post:

Higher Covid-19 Vaccination Rates Linked To Lower Prevalence Of Pediatric Asthma Symptoms - Forbes

University Fights Off Fired Nurse’s Vaccine Religious Bias Case – Bloomberg Law

July 9, 2024

Accommodating a Christian nurses request for a religious exemption to a Covid-19 vaccination policy would have posed an undue hardship for the Oregon university behind the childrens hospital where she worked, a federal judge said.

Oregon Health & Science University demonstrated that it couldnt accommodate the nurses religion-based objections to the vaccine without posing an undue hardship during an earlier stage of the coronavirus pandemic, the US District Court for the District of Oregon said, granting summary judgment in favor of Oregons largest public hospital system.

Plaintiff Brittany MacDonald worked as a registered nurse at OHSUs Doernbecher Childrens Hospital ...

Continue reading here:

University Fights Off Fired Nurse's Vaccine Religious Bias Case - Bloomberg Law

Heres how you should time your next COVID shot, according to experts – WOODTV.com

July 6, 2024

Pete Zimmerman and Alix Martichoux

1 day ago

(WGN Radio) As the summer surge in COVID-19 cases and hospitalizations continues, an updated vaccine to protect against the virus is on the way.

An updated booster shot will be available to Americans this fall, the Centers for Disease Control and Prevention confirmed. The CDC advises everyone 6 months and older get the new booster as soon as its available, regardless of whether or not theyve been vaccinated before.

These are the top vaccine people in the country and their recommendation is that everyone eligible should get it, said Dr. Jeffrey Kopin, chief medical officer forNorthwestern Medicine Lake Forest Hospital.

The shots are expected to become available in August and September, the Associated Press reports.

The updated booster wont be a combination COVID-influenza vaccine, Kopin said. That shot wont be available until at least next year, he said.

Listen to Dr. Kopins full interview with WGN Radio below.

Health officials have told Americans to expect a yearly update to COVID-19 vaccines, just like they are recommended to get a new shot each fall to protect against the latest flu strains.

But many Americans arent heeding the CDCs advice.

As of last month, less than one-quarter of U.S. adults and 14% of children were up to date in their COVID shots. Surveys show shrinking percentages of Americans think COVID-19 is a major health threat to the U.S. population, and indicate that fewer doctors are urging patients to get updated vaccines.

CDC officials on Thursday presented recent survey information in which about 23% of respondents said they would definitely get an updated COVID-19 shot this fall, but 33% said they definitely would not.

About 1.2 million U.S. COVID-associated deaths have been reported since early 2020, according to the CDC. The toll was most intense in the winter of 2020-2021, when weekly deaths surpassed 20,000. About 1 out of every 100 Americans ages 75 and older were hospitalized with COVID in the last four years, CDC officials said Thursday.

The Associated Press contributed to this report.

Visit link:

Heres how you should time your next COVID shot, according to experts - WOODTV.com

Everyone Needs an Updated COVID Shot This Fall, CDC Says – Verywell Health

July 6, 2024

Key Takeaways

The Centers for Disease Control and Prevention (CDC) on Thursday recommended that everyone 6 months and older get an updated COVID vaccine when manufacturers release them this fall.

The agency made its decision following a meeting of the CDCs Advisory Committee on Immunization Practices (ACIP), which found that the virus continues to cause illness, especially as it mutates over time, leaving people less protected even if they were vaccinated or previously had COVID.

Anticipating new fall vaccines, the Food and Drug Administration (FDA) has asked vaccine manufacturers to target a newer COVID variant called KP.2.

Pfizer and Moderna said they will be able to create such a vaccine by the fall thanks to mRNA technology, which is faster to manipulate and update than protein subunit vaccines like Novavax. Novavax said its fall vaccine will target an earlier COVID variant called JN.1, which it was in the process of developing before the FDA asked the brands to pivot. Novavax expects its vaccine to be protective against KP.2 as well.

Given the manufacturing time needed for vaccines, its difficult to fully match them to the variants circulating at the time they are administered, Anne Monroe, MD, an associate professor in the Department of Epidemiology at George Washington University in Washington, DC, told Verywell.

Still, Monroe advises everyone eligible to get the updated vaccine when its available.

Updated vaccines can help protect against infection, hospitalizations, and severe disease and may prevent you from spreading the virus to someone vulnerable if you get sick, she said. People are still dying of this virus.

Studies have shown that vaccines are somewhat protective against getting a COVID infection but very protective against severe disease, Robert Hopkins, MD, medical director of the National Foundation for Infectious Disease and a liaison to ACIP, told Verywell. Data presented during the ACIP meeting showed that only 11% of hospitalized adult patients between October 2023 and March 2024 had received the 2023-2024 COVID vaccine. In 2023, according to the agency, more than 916,300 people were hospitalized due to COVID, and more than 75,500 people died from the virus.

The recommendation for the updated COVID vaccine applies even to people who have never received a vaccine for the virus. Older vaccines are no longer available, so first-timers will start with the vaccine that will be updated this fall.

If you are 65 and older and/or have a chronic illness, you may have gotten an updated COVID vaccine targeting XBB.1.5 any time since last spring. Hopkins said you are still eligible for another one this coming fall as long as it has been four months since your last dose.

Hopkins says that since COVID cases are rising right now, there are a few things people should do if they get sick:

Use this search engine to find a COVID vaccine in your neighborhood and to find updated vaccines when they become available in the fall. The new shots are expected by August or September.

The information in this article is current as of the date listed, which means newer information may be available when you read this. For the most recent updates on COVID-19, visit ourcoronavirus news page.

By Fran Kritz Kritz is a healthcare reporter with a focus on health policy. She is a former staff writer for Forbes Magazine and U.S. News and World Report.

Thanks for your feedback!

What is your feedback?

Continued here:

Everyone Needs an Updated COVID Shot This Fall, CDC Says - Verywell Health

CDC Recommends Americans Get New COVID ShotsHere’s What to Know – Health.com

July 6, 2024

The Centers for Disease Control and Prevention (CDC) is recommending that all Americans six months and older get an updated COVID-19 vaccine in the fall, regardless of whether theyve been vaccinated against the virus in the past.

Our top recommendation for protecting yourself and your loved ones from respiratory illness is to get vaccinated, Mandy Cohen, MD, MPH, director of the CDC, said in a statement. Make a plan now for you and your family to get both updated flu and COVID vaccines this fall, ahead of the respiratory virus season.

The guidance comes amid a summer COVID wave, which is now a familiar pattern in the United States. Data from the CDC show that COVID-related emergency room visits for the week ending June 22 were up more than 23% compared to the week before, with deaths increasing by more than 14%.

Heres what you need to know about the vaccine available this fall.

Luis Alvarez / Getty Images

The vaccines from Moderna and Pfizer will target the KP.2 strain of COVID-19, which CDC data show is the second-most common strain of the virus in the U.S. right now. Currently, the KP.3 virus variant is the most common. Both KP.2 and KP.3, along with KP.1.1, are part of the so-called FLiRT variants that are heavily circulating now in the country.

The Novavax vaccine, on the other hand, will target JN.1, the parent variant of KP.2 that was the top strain circulating this past winter.

Officials from the Food and Drug Administration initially recommended that vaccine manufacturers target JN.1. As KP.2 gained dominance, they changed the recommendation to suggest that a new vaccine focus on that strain instead.

So far, vaccines have lowered the risk of hospitalization or death from a COVID infection, Amesh A. Adalja, MD, senior scholar at the Johns Hopkins Center for Health Security, told Health. Its unclear how well and how durably current vaccine technologies are able to do that in the face of a heavily mutating virus, he told Health.

CDC officials did not provide a specific date for when the vaccines will be available, saying only that Moderna, Novavax, and Pfizer will roll out updated vaccines in the fall.

The last COVID-19 vaccine, which was an update to the previous vaccine, was available in the fall of 2023, but only about 20% of Americans actually got it.

Pediatricians and family doctors are going to have to be very, very persuasive to get patients to receive the updated vaccine, John Sellick, DO, an infectious disease expert and professor of medicine at the University at Buffalo, told Health. Last years updated vaccine was not as widely accepted as we had hoped," he continued. "This year will be another challenge.

Adalja stressed the importance of vaccination in people who are considered high risk, which are those who are immunocompromised, over 65, or who have serious underlying health conditions like cancer, diabetes, and heart conditions. The key message should be to vaccinate the high-risk, he said.

However, William Schaffner, MD, an infectious disease specialist and professor at the Vanderbilt University School of Medicine, told Health that its going to be a hard sell to get Americans as a whole to get another COVID-19 vaccine.

We need to get into this framework of, Heres your annual flu shot and your annual COVID shot, he said. Hopefully, by making it part of health maintenance, well get people to accept this better.

Continue reading here:

CDC Recommends Americans Get New COVID ShotsHere's What to Know - Health.com

Partial win for Moderna in Covid-19 vaccine patent battle with Pfizer and BioNTech – The Global Legal Post

July 6, 2024

YOUR PRIVACY - PLEASE READ CAREFULLY DATA PROTECTION STATEMENT

Below we explain how we will communicate with you. We set out how we use your data in our Privacy Policy.

Global City Media, and its associated brands will use the lawful basis of legitimate interests to use the contact details you have supplied to contact you regarding our publications, events, training, reader research, and other relevant information. We will always give you the option to opt out of our marketing.

By clicking submit, you confirm that you understand and accept the Terms & Conditions and Privacy Policy

View original post here:

Partial win for Moderna in Covid-19 vaccine patent battle with Pfizer and BioNTech - The Global Legal Post

Page 9«..891011..2030..»